Current Research Studies

A REsearch Study to Advance the CF THerapeutics Pipeline for People without Modulators

CF REACH Site

  • Phase: N/A

What is the goal of the study?

To collect data on key clinical outcome endpoints, including changes in lung function, that are often used as endpoints in therapeutic trials to establish a repository of control data in people with cystic fibrosis who are ineligible for and/or not taking CFTR modulators.

Who can participate in the study?

Diagnosis of cystic fibrosis Age 12 years and older Not eligible for or not taking CF modulator therapy

Study Team: